European Cardiovascular Disease Statistics, 2008. ,
An??lisis cr??tico y propuestas de mejora de los sistemas de informaci??n sobre enfermedades cardiovasculares en Espa??a, Medicina Cl??nica, vol.131, issue.8, pp.302-311, 2008. ,
DOI : 10.1016/S0025-7753(08)72264-4
Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline, BMC Public Health, vol.80, issue.1, p.148, 2008. ,
DOI : 10.1136/hrt.80.1.40
Explaining the Decrease in Coronary Heart Disease Mortality in Italy Between, Am J Public Health, 1980. ,
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002, European Heart Journal, vol.30, issue.9, pp.1046-1056, 1986. ,
DOI : 10.1093/eurheartj/ehn554
How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study, Circulation, vol.117, issue.5, pp.598-604, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.107.705947
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis, JAMA, vol.295, issue.2, pp.180-189, 2006. ,
DOI : 10.1001/jama.295.2.180
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, European Journal of Cardiovascular Prevention & Rehabilitation, vol.371, issue.1, pp.121-137, 2009. ,
DOI : 10.1097/HJR.0b013e3283294b1d
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, The Lancet, vol.373, issue.9667, pp.929-940, 2009. ,
DOI : 10.1016/S0140-6736(09)60330-5
European Practice Assessment of Cardiovascular risk management (EPA Cardio): protocol of an international observational study in primary care, Implementation Science, vol.23, issue.5, p.3, 2009. ,
DOI : 10.1093/fampra/cmi091
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, European Heart Journal, vol.24, issue.11, pp.987-1003, 2003. ,
DOI : 10.1016/S0195-668X(03)00114-3
Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement, Pediatric Research, vol.45, issue.4, Part 2 of 2, pp.1458-1465, 1999. ,
DOI : 10.1203/00006450-199904020-00719
Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey, Family Practice, vol.19, issue.6, pp.596-604, 2002. ,
DOI : 10.1093/fampra/19.6.596
Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology, European Journal of Cardiovascular Prevention & Rehabilitation, vol.24, issue.5, pp.839-845, 2006. ,
DOI : 10.1097/01.hjr.0000219112.02544.24
A global survey of physicians??? perceptions on cholesterol management: the From The Heart study, International Journal of Clinical Practice, vol.12, issue.Suppl. 2, pp.1078-1085, 2007. ,
DOI : 10.1111/j.1742-1241.2007.01420.x
Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: Results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study), Nutrition, Metabolism and Cardiovascular Diseases, vol.13, issue.4, pp.211-217, 2003. ,
DOI : 10.1016/S0939-4753(03)80013-3
National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines, Circulation, vol.111, issue.4, pp.499-510, 2005. ,
DOI : 10.1161/01.CIR.0000154568.43333.82
Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events, BMC Family Practice, vol.282, issue.1, p.42, 2008. ,
DOI : 10.1001/jama.282.15.1458
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980???2000, New England Journal of Medicine, vol.356, issue.23, pp.2388-2398, 1980. ,
DOI : 10.1056/NEJMsa053935
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation, Diabetes Care, vol.31, issue.4, pp.811-822, 2008. ,
DOI : 10.2337/dc08-9018
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Circulation, pp.477-484, 2000. ,
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment, The Lancet, vol.361, issue.9359, pp.777-780, 2003. ,
DOI : 10.1016/S0140-6736(03)12663-3
C-reactive protein and coronary heart disease: a critical review, Journal of Internal Medicine, vol.7, issue.4, pp.295-314, 2008. ,
DOI : 10.1111/j.1365-2796.2008.02015.x
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein, New England Journal of Medicine, vol.359, issue.21, pp.2195-2207, 2008. ,
DOI : 10.1056/NEJMoa0807646
Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals, Circulation, vol.120, issue.1, pp.28-34, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.838466
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2, BMJ, vol.336, issue.7659, pp.1475-1482, 2008. ,
DOI : 10.1136/bmj.39609.449676.25
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA) BMC Public Health, p.382, 2010. ,